Anti-KAT3B / p300 antibody [EPR23753-55]
- 20ul selling size
- RabMAb
- Advanced Validation
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal KAT3B / p300 antibody. Suitable for ChIC/CUT&RUN-seq, Flow Cyt (Intra), WB, ICC/IF and reacts with Human, Mouse, Rat samples. Cited in 5 publications.
View Alternative Names
P300, EP300, Histone acetyltransferase p300, p300 HAT, E1A-associated protein p300, Histone butyryltransferase p300, Histone crotonyltransferase p300, Protein 2-hydroxyisobutyryltransferase p300, Protein isonicotinyltransferase p300, Protein lactyltransferas p300, Protein propionyltransferase p300
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-KAT3B / p300 antibody [EPR23753-55] (AB259330)
Immunofluorescent analysis of 100% methanol-fixed, 0.1% TritonX-100 permeabilized HeLa cells labelling KAT3B / p300 with ab259330 at 1/500 (0.926 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2ug/ml dilution (Green). Confocal image showing mainly nuclear staining in HeLa cells and no staining in HCT-15 cells. Negative control : HCT-15 (PMID : 14732695) is observed. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue).
Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2ug/ml dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-KAT3B / p300 antibody [EPR23753-55] (AB259330)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized HeLa (Human cervix adenocarcinoma epithelial cell) cells labelling KAT3B / p300 with ab259330 at 1/500 dilution (0.1ug) (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/2000 dilution was used as the secondary antibody.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-KAT3B / p300 antibody [EPR23753-55] (AB259330)
Immunofluorescent analysis of 100% methanol-fixed, 0.1% TritonX-100 permeabilized NIH/3T3 cells labelling KAT3B / p300 with ab259330 at 1/500 (0.926 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2ug/ml dilution (Green). Confocal image showing nuclear staining in NIH/3T3 cells is observed. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2ug/ml dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-KAT3B / p300 antibody [EPR23753-55] (AB259330)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized NIH/3T3 (Mouse embryonic fibroblast) cells labelling KAT3B / p300 with ab259330 at 1/500 dilution (0.1ug) (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/2000 dilution was used as the secondary antibody.
- WB
Lab
Western blot - Anti-KAT3B / p300 antibody [EPR23753-55] (AB259330)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Fresh lysates were used in this WB.
The ~100KDa signal is a non-target band.
Lane 2 of the blot was developed using a higher-sensitivity ECL substrate.
Exposure time : 3 minutes
All lanes:
Western blot - Anti-KAT3B / p300 antibody [EPR23753-55] (ab259330) at 1/1000 dilution
Lane 1:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate at 10 µg
Lane 2:
K562 (human chronic myelogenous leukemia lymphoblast), whole cell lysate at 10 µg
Lane 3:
RAW264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage), whole cell lysate at 10 µg
Lane 4:
PC-12 (rat adrenal gland pheochromocytoma), whole cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 264 kDa
Observed band size: 300 kDa
false
- WB
Lab
Western blot - Anti-KAT3B / p300 antibody [EPR23753-55] (AB259330)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Fresh lysates were used in this WB.
The ~100KDa signal is a non-target band.
Negative control : HCT15 (PMID : 14732695)
Exposure time : 3 minutes
All lanes:
Western blot - Anti-KAT3B / p300 antibody [EPR23753-55] (ab259330) at 1/1000 dilution
Lane 1:
K562 (human chronic myelogenous leukemia lymphoblast), whole cell lysate at 20 µg
Lane 2:
HCT15 (human colon epithelial cell), whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 264 kDa
Observed band size: 300 kDa
false
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-KAT3B / p300 antibody [EPR23753-55] (AB259330)
ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2.5 x 10^5 HeLa (Human cervix adenocarcinoma epithelial cell line) cells and 5 µg of ab259330 [EPR23753-55]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. Additional screenshots of mapped reads can be found in the Protocol booklet in the Product Protocol section. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- WB
Lab
Western blot - Anti-KAT3B / p300 antibody [EPR23753-55] (AB259330)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
This antibody has no cross-reaction with human CREBBP.
Both recombinant proteins were made in-house.
The sample loaded onto lane 1 was purified EP300 recombinant protein expressed from an E.coli expression system.
The sample loaded onto lane 2 is E.coli extracts containing recombinant CREBBP protein.
Exposure time : 15 seconds
All lanes:
Western blot - Anti-KAT3B / p300 antibody [EPR23753-55] (ab259330) at 1/1000 dilution
Lane 1:
His-tagged human EP300 recombinant protein at 0.01 µg
Lane 2:
His-tagged human CREBBP recombinant protein at 0.01 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 264 kDa
false
Related conjugates and formulations (1)
-
Anti-KAT3B / p300 antibody [EPR23753-55] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
KAT3B/p300 influences multiple cellular activities like cell growth differentiation and apoptosis. It functions as a transcriptional coactivator and integrates various signaling pathways into the cell's gene expression program. p300 often forms complexes with other transcription factors enhancing or repressing their activity based on the cellular context. By modifying transcription factors it plays an essential role in controlling cell fate decisions.
Pathways
P300 participates in the regulation of significant cellular processes including the Wnt signaling pathway and the p53 pathway. In the Wnt signaling pathway p300 acts alongside beta-catenin to regulate gene expression while in the p53 pathway it acetylates the p53 protein influencing the cell’s response to DNA damage. These pathways highlight p300's interaction with important proteins such as CBP (CREB-binding protein) which shares a similar functional repertoire and works synergistically in gene regulation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download chicCutRunSequencingBooklet|en
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
PloS one 20:e0328139 PubMed40825027
2025
Applications
Unspecified application
Species
Unspecified reactive species
Renal failure 46:2369342 PubMed39230047
2024
Applications
Unspecified application
Species
Unspecified reactive species
Tobacco induced diseases 21:122 PubMed37794858
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell discovery 9:47 PubMed37156794
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell biology international 47:776-786 PubMed36576012
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com